摘要
目的:观察老年女性骨质疏松症(OP)患者静滴唑来膦酸后急性期反应(APR)的发生情况。方法:47例老年女性OP患者静滴唑来膦酸注射液5 mg后,记录她们在72 h内发热、肌痛、流感样症状、头痛头晕、恶心呕吐等APR的发生情况。结果:35例(74.47%)患者出现1个或1个以上的APR,其中发热19例(40.43%),肌痛18例(38.30%),流感样症状14例(29.79%),头痛头晕13例(27.66%),恶心呕吐12例(25.53%)。发热患者伴随其他APR的平均个数(3.35±1.41)个明显高于不发热的患者的平均个数(1.40±0.63)个,差异有统计学意义(P<0.01)。且在发热患者中,最高体温与其他APR间具有相关性(r=0.577,P<0.05)。结论:老年女性OP患者静脉输注唑来膦酸后,易出现发热等APR,应重视静脉输注后的观察和处理。
Objective: To investigate the incidence of acute-phase reaction( APR) of zoledronic acid injection in elder osteoporotic women. Methods: APR( ≤72h after 5 mg zoledronic acid injection infusion),including fever,myalgia,influenza-like symptoms,headache,dizziness,nausea and vomiting,were recorded. Results: 35( 74. 47%) cases had one or more APR,and the most common APR was fever( 40. 43%),followed by myalgia( 38. 30%),influenza-like symptoms( 29. 79%),headache and dizziness( 27. 66%),nausea and vomiting( 25. 53%). There was a significant difference in the average number of other APR observed between subjects presented with fever( 3. 35 ± 1. 41) and those without( 1. 40 ±0. 63)( P〈0. 01). Moreover,the higher body temperature were correlated to more incidences of other APR in feverish cases( P〈0. 05). Conclusion: There was a high incidence of APR in older osteoporotic women after treatment with zoledronic acid injection,as a result,close observation and proper treatment should be implemented to secure the safety of the patients.
出处
《药物流行病学杂志》
CAS
2016年第7期432-434,共3页
Chinese Journal of Pharmacoepidemiology
基金
浙江省医药卫生平台重点资助项目(编号:2016ZDAD02)
浙江省人民医院优秀青年人员科研启动基金(编号:zry2015C002)
关键词
唑来膦酸
骨质疏松症
急性期反应
发热
Zoledronic acid
Osteoporosis
Adverse-phase reaction
Fever